Inventor · disambiguated record
Heow Tan
Also filed as: TAN HEOW MENG · Tan Heow
6 granted patents·7 pending applications·78 citations·filing 2016–2024
83Inventor score
Top patents by PatentIndex Score
13 records- 0195US10010507B1Pharmaceutical formulations of a bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2018·Granted Jul 3, 2018·23 cites·28 claims
- 0295US9655857B2Pharmaceutical formulations of a Bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2016·Granted May 23, 2017·32 cites·37 claims
- 0394US10828259B2Pharmaceutical formulations of a Bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2020·Granted Nov 10, 2020·5 cites·25 claims
- 0494US10213386B2Pharmaceutical formulations of a Bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2018·Granted Feb 26, 2019·18 cites·23 claims
- 0578US2022331252A1Pharmaceutical formulations of a bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2021·Application pending·0 cites
- 0673US12215113B2Crystalline forms of N[4[4-(4-Morpholinyl)-7H-Pyrrolo[2-3-D]Pyrimidin-6-yl]Phenyl]-4-[[3(R)-[(1-Oxo-2-Protein-1-yl)Amino]-1-Piperidinyl]Methyl]2-Pyridinecarboxamide]BIOMEA FUSION INC·Filed 2024·Granted Feb 4, 2025·0 cites·35 claims
- 0769US12018032B2Crystalline forms of N-[4-[4-(4-morpholinyl)-7H-pyrrolo[2,3-d]pyrimidin-6-yl]phenyl]-4-[[3(r)-[(1-oxo-2-propen-1-yl)amino]-1-piperidinyl]methyl]-2-pyridinecarboxamide as an irreversible inhibitor of menin-MLL interactionBIOMEA FUSION INC·Filed 2022·Granted Jun 25, 2024·0 cites·19 claims
- 0869US2024417404A1CRYSTALLINE FORMS OF N-[4-[4-(4-MORPHOLINYL)-7H-PYRROLO[2,3-d]PYRIMIDIN-6-YL]PHENYL]-4-[[3(R)-[(1-OXO-2-PROPEN-1-YL)AMINO]-1-PIPERIDINYL]METHYL]-2-PYRIDINECARBOXAMIDE AS IRREVERSIBLE INHIBITORS OF MENIN-MLL INTERACTIONBIOMEA FUSION INC·Filed 2024·Application pending·0 cites
- 0967US2019117579A1Pharmaceutical formulations of a brutons tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2018·Application pending·0 cites
- 1066US2019015340A1Pharmaceutical formulations of a bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2018·Application pending·0 cites
- 1162US2017258729A1Pharmaceutical Formulations of a Bruton's Tyrosine Kinase InhibitorPHARMACYCLICS LLC·Filed 2017·Application pending·0 cites
- 1261US2024343731A1Crystalline forms of an irreversible inhibitor of menin-mll interactionBIOMEA FUSION INC·Filed 2024·Application pending·0 cites
- 1357US2025243207A1Synthetic methods for preparing a pyridinecarboxamide compoundBIOMEA FUSION INC·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Heow Tan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →